Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -512,540 | -383,991 | -257,089 | -132,970 | -422,773 |
| Depreciation Amortization | 930 | -294 | -1,215 | -1,563 | -27,322 |
| Accounts payable and accrued liabilities | -7,520 | -4,112 | -43 | -2,639 | 1,437 |
| Other Working Capital | 149 | -4,867 | 1,354 | -21,933 | 16,937 |
| Other Operating Activity | 106,381 | 79,202 | 50,227 | 27,637 | 84,027 |
| Operating Cash Flow | $-412,600 | $-314,062 | $-206,766 | $-131,468 | $-347,694 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9,502 | -7,978 | -9,356 | -5,078 | -15,912 |
| Purchase Of Investment | -441,263 | -188,555 | -137,926 | -137,926 | -1,229,964 |
| Sale Of Investment | 706,046 | 431,046 | 323,965 | 161,752 | 1,157,120 |
| Investing Cash Flow | $255,281 | $234,513 | $176,683 | $18,748 | $-88,756 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -8,168 | -8,152 | -6,791 | -4,357 | -32,338 |
| Common Stock Issued | 8,459 | 5,235 | 4,652 | 595 | 516,642 |
| Other Financing Activity | 188,925 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $189,216 | $-2,917 | $-2,139 | $-3,762 | $484,304 |
| Beginning Cash Position | 176,535 | 176,535 | 176,535 | 176,535 | 128,681 |
| End Cash Position | 208,432 | 94,069 | 144,313 | 60,053 | 176,535 |
| Net Cash Flow | $31,897 | $-82,466 | $-32,222 | $-116,482 | $47,854 |
| Free Cash Flow | |||||
| Operating Cash Flow | -412,600 | -314,062 | -206,766 | -131,468 | -347,694 |
| Capital Expenditure | -9,502 | -7,978 | -9,356 | -5,078 | -15,912 |
| Free Cash Flow | -422,102 | -322,040 | -216,122 | -136,546 | -363,606 |